Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis: findings from an open-label treatment extension. (Q34157346)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis: findings from an open-label treatment extension. |
scientific article |
Statements
Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis: findings from an open-label treatment extension (English)
Alberto Martini
Daniel J Lovell
Edward H Giannini
Ruben Cuttica
Patricia Woo
Silvia Meiorin
Earl D Silverman
Zsolt Balogh
Michael Henrickson
Joyce Davidson
Lisa Imundo
Joachim Oppermann
Stephen Xu
Yaung-Kaung Shen
Sudha Visvanathan
Adedigbo Fasanmade
Alan Mendelsohn
Paediatric Rheumatology INternational Trials Organization (PRINTO)
Pediatric Rheumatology Collaborative Study Group (PRCSG)
Nicolino Ruperto
1 April 2010
1 reference
1 reference
1 reference
1 reference
1 reference